PCA3 and pachyonychia congenita: Nine MRMGPS-based genes (CTSZ, FCGRT, GOLM1, SMIM22, ACPP, FAM3B, TFF3, PCA3, and MSMB) were found to be associated with PC prognosis and prediction of treatment response with associations linked to tumor microenvironment [146].